⌘+K

Sweden

Healthcare

Elicera Therapeutics

Company description

Elicera Therapeutics is a Swedish clinical-stage biotechnology company developing next-generation immuno-oncology treatments, focusing on enhanced CAR T-cell therapies and oncolytic viruses. The company’s proprietary and commercially available iTANK platform is an engineered ‘arming’ technology designed to boost the efficacy of CAR T therapies and oncolytic viruses, particularly in solid tumours. iTANK is already integrated into three of Elicera’s lead candidates (ELC-301, ELC-401 and ELC-201) and is also available for out-licensing to other CAR T/TCR T developers.

Key industry drivers

  • Increasing incidence and prevalence of cancer

  • Ever growing demand for more effective treatments in difficult-to-treat population

Industry outlook

  • The market for oncology drugs is expected to grow at double-digit rate over the coming five years (IQVIA)

  • Larger pharmaceutical companies face patent cliffs, which we believe will continue to drive interest in in-licensing

  • Key peers

    BioInvent, Faron Pharmaceuticals

    Shareholders

    Name

    Capital

    Votes

    Avanza

    10.1 %

    10.1 %

    Di Yu

    5.2 %

    5.2 %

    Magnus Essand

    5.1 %

    5.1 %

    Jamal El-Mosleh

    4.1 %

    4.1 %

    Nordnet

    3.7 %

    3.7 %

    Other owners

    71.7 %

    71.7 %

    About DNB Carnegie Access

    DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

    Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

    Private Banking

    Tailored wealth management. Your financial future, personalized.

    Montrose

    A digital investment platform designed for passionate investors.

    DNB Carnegie

    Leading Nordic investment bank and wealth management.

    © Copyright DNB Carnegie Investment Bank AB